Literature DB >> 9871850

Sumatriptan for post-ECT headache.

R M Fantz1, J S Markowitz, C H Kellner.   

Abstract

A 27-year-old woman receiving electroconvulsive therapy (ECT) for the treatment of depression developed post-ECT headaches refractory to treatment with acetaminophen and various nonsteroidal antiinflammatory drugs. The patient was then treated successfully with oral sumatriptan. This case suggests that sumatriptan may be a useful treatment of post-ECT headaches that are unresponsive to conventional analgesics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871850

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  2 in total

1.  Increased Risk of Pain after Electroconvulsive Therapy among Depressed Patients: a Nationwide Study in Taiwan.

Authors:  Ching-En Lin; Chi-Hsiang Chun; Li-Fen Chen; Wu-Chien Chien
Journal:  Psychiatr Q       Date:  2020-03

2.  The Incidence and Predictors of Headache and Myalgia in Patients After Electroconvulsive Therapy (ECT).

Authors:  Mohammad Haghighi; Abbas Sedighinejad; Bahram Naderi Nabi; Cyrus Emiralavi; Gelareh Biazar; Kaveh Mirmozaffari; Cyrus Zahedan; Mehdi Jafari
Journal:  Anesth Pain Med       Date:  2016-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.